ATP2B4 and breast carcinoma: In summary, our findings suggest that loss of PMCA4 is implicated in luminal type breast carcinomas, and that elevated PMCA4 levels are associated with longer relapse-free patient survival at the early onset of LUMA and LUMB1 breast cancer cases.